Clinical Trial Update: Combined THC and CBD for OUD and Chronic Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Yale University is evaluating a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) for chronic pain and opioid use di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)
• Tetrahydrocannabinol (THC) (tetrahydrocannabinol)

Snippet

Sponsor: Yale University | Conditions: Chronic Pain, Opioid Use Disorder | Phase 2 | Status: RECRUITING